Treg Modulation With CD28 and IL-6 Receptor Antagonists

Conditions:   Living-Donor Kidney Transplant;   Kidney Transplant Recipients Interventions:   Biological: lulizumab pegol;   Biological: antithymocyte globulin (rabbit);   Drug: methylprednisolone;   Biological: tocilizumab;   Drug: Prednisone;   Drug: everolimus;   Biological: belatacept;   Drug: mycophenolate mofetil;   Drug: mycophenolic acid Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Bristol-Myers Squibb;   Clinical Trials in Organ Transplantation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials